Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds
Name:
s13321-022-00661-0.pdf
Size:
1.190Mb
Format:
PDF
Description:
Final Published Version
Author
Bajorath, J.Chávez-Hernández, A.L.
Duran-Frigola, M.
Fernández-de Gortari, E.
Gasteiger, J.
López-López, E.
Maggiora, G.M.
Medina-Franco, J.L.
Méndez-Lucio, O.
Mestres, J.
Miranda-Quintana, R.A.
Oprea, T.I.
Plisson, F.
Prieto-Martínez, F.D.
Rodríguez-Pérez, R.
Rondón-Villarreal, P.
Saldívar-Gonzalez, F.I.
Sánchez-Cruz, N.
Valli, M.
Affiliation
BIO5 Institute, University of ArizonaIssue Date
2022-12-02Keywords
ADME profileAntibiotic resistance
Artificial intelligence
Career development
Drug discovery
Ligand-based drug design
Machine learning
Natural products
Peptides
Structure-based drug design
Virtual screening
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Bajorath, J., Chávez-Hernández, A.L., Duran-Frigola, M. et al. Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds. J Cheminform 14, 82 (2022). https://doi.org/10.1186/s13321-022-00661-0Journal
Journal of CheminformaticsRights
© The Author(s) 2022. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, (http://creativecommons.org/licenses/by/4. 0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
We report the main conclusions of the first Chemoinformatics and Artificial Intelligence Colloquium, Mexico City, June 15–17, 2022. Fifteen lectures were presented during a virtual public event with speakers from industry, academia, and non-for-profit organizations. Twelve hundred and ninety students and academics from more than 60 countries. During the meeting, applications, challenges, and opportunities in drug discovery, de novo drug design, ADME-Tox (absorption, distribution, metabolism, excretion and toxicity) property predictions, organic chemistry, peptides, and antibiotic resistance were discussed. The program along with the recordings of all sessions are freely available at https://www.difacquim.com/english/events/2022-colloquium/. © 2022, The Author(s).Note
Open access journalISSN
1758-2946Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1186/s13321-022-00661-0
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2022. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, (http://creativecommons.org/licenses/by/4. 0/).

